Literature DB >> 19300870

Biomarkers for Alzheimer's disease trials--biomarkers for what? A discussion paper.

S Lovestone1, M Thambisetty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19300870     DOI： 10.1007/s12603-009-0033-x

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN： 1279-7707            Impact factor:   4.075


× No keyword cloud information.
  5 in total

Review 1.  Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.

Authors: 
Journal:  Neurobiol Aging       Date:  1998 Mar-Apr       Impact factor: 4.673

2.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

Authors:  Julie A Schneider; Zoe Arvanitakis; Woojeong Bang; David A Bennett
Journal:  Neurology       Date:  2007-06-13       Impact factor: 9.910

Review 3.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Steven T Dekosky; Pascale Barberger-Gateau; Jeffrey Cummings; André Delacourte; Douglas Galasko; Serge Gauthier; Gregory Jicha; Kenichi Meguro; John O'brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182

4.  Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.

Authors:  Clive Holmes; Delphine Boche; David Wilkinson; Ghasem Yadegarfar; Vivienne Hopkins; Anthony Bayer; Roy W Jones; Roger Bullock; Seth Love; James W Neal; Elina Zotova; James A R Nicoll
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

5.  Diagnosing Alzheimer's disease--non-clinicians and computerised algorithms together are as accurate as the best clinical practice.

Authors:  Catherine M L Foy; Helen Nicholas; Paul Hollingworth; Harry Boothby; Julie Willams; Richard G Brown; Safa Al-Sarraj; Simon Lovestone
Journal:  Int J Geriatr Psychiatry       Date:  2007-11       Impact factor: 3.485
  5 in total
  3 in total

1.  Imaging and biomarkers will be used for detection and monitoring progression of early Alzheimer's disease.

Authors:  M W Weiner
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

2.  Use of biomarkers in Alzheimer's trials.

Authors:  B Vellas
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

3.  The healthy ageing gene expression signature for Alzheimer's disease diagnosis: a random sampling perspective.

Authors:  Laurent Jacob; Terence P Speed
Journal:  Genome Biol       Date:  2018-07-25       Impact factor: 13.583
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.